Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe- and gene-specific scoring alternatives on recommended multi-gene panels.
<h4>Background</h4>In colorectal cancer a distinct subgroup of tumours demonstrate the CpG island methylator phenotype (CIMP). However, a consensus of how to score CIMP is not reached, and variation in definition may influence the reported CIMP prevalence in tumours. Thus, we sought to c...
Main Authors: | Marianne Berg, Hanne R Hagland, Kjetil Søreide |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24466191/pdf/?tool=EBI |
Similar Items
-
Investigation of CpG Island Methylator Phenotype (CIMP) in the Prognosis of Resectable NSCLC
by: Cheng-Hung Tsai, et al.
Published: (2015) -
18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high
by: Kirkner Gregory J, et al.
Published: (2007-05-01) -
B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP).
by: Eva S Schernhammer, et al.
Published: (2011-01-01) -
Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer
by: Jiang Liu, et al.
Published: (2019-11-01) -
Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP).
by: Laura A E Hughes, et al.
Published: (2011-04-01)